Philip P Boudreau is EVP AND CFO of ABBOTT LABORATORIES. Currently has a direct ownership of 56,553 shares of ABT, which is worth approximately $7.17 Million. The most recent transaction as insider was on Feb 28, 2025, when has been sold 4,908 shares (Common shares without par value) at a price of $135.87 per share, resulting in proceeds of $666,849. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.6K
45.13% 3M change
43.71% 12M change
Total Value Held $7.17 Million

Philip P Boudreau Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2025
SELL
Payment of exercise price or tax liability
$666,849 $135.87 p/Share
4,908 Reduced 7.99%
56,553 Common shares without ...
Feb 25 2025
BUY
Grant, award, or other acquisition
-
22,495 Added 26.79%
61,461 Common shares without ...
Sep 01 2024
SELL
Payment of exercise price or tax liability
$43,835 $113.27 p/Share
387 Reduced 0.98%
38,966 Common shares without ...
Feb 29 2024
SELL
Payment of exercise price or tax liability
$208,646 $120.05 p/Share
1,738 Reduced 4.23%
39,353 Common shares without ...
Feb 21 2024
BUY
Grant, award, or other acquisition
-
23,024 Added 35.91%
41,091 Common shares without ...
Sep 01 2023
BUY
Grant, award, or other acquisition
-
2,620 Added 12.66%
18,067 Common shares without ...
Jun 16 2023
SELL
Open market or private sale
$848,000 $106.0 p/Share
8,000 Reduced 34.12%
15,447 Common shares without ...
Feb 28 2023
SELL
Payment of exercise price or tax liability
$147,360 $99.77 p/Share
1,477 Reduced 5.93%
23,447 Common shares without ...
Feb 17 2023
BUY
Grant, award, or other acquisition
-
4,855 Added 16.3%
24,924 Common shares without ...
Feb 28 2022
SELL
Payment of exercise price or tax liability
$145,913 $122.41 p/Share
1,192 Reduced 5.61%
20,069 Common shares without ...
Feb 22 2022
SELL
Payment of exercise price or tax liability
$112,819 $116.79 p/Share
966 Reduced 4.35%
21,261 Common shares without ...
Feb 18 2022
BUY
Grant, award, or other acquisition
-
5,351 Added 19.4%
22,227 Common shares without ...
Oct 25 2021
SELL
Open market or private sale
$1,011,920 $126.49 p/Share
8,000 Reduced 32.16%
16,876 Common shares without ...
Feb 26 2021
SELL
Payment of exercise price or tax liability
$85,592 $121.58 p/Share
704 Reduced 2.75%
24,876 Common shares without ...
Feb 22 2021
SELL
Payment of exercise price or tax liability
$115,288 $123.04 p/Share
937 Reduced 3.53%
25,580 Common shares without ...
Feb 19 2021
BUY
Grant, award, or other acquisition
-
4,997 Added 15.86%
26,517 Common shares without ...
Feb 16 2021
SELL
Payment of exercise price or tax liability
$120,921 $128.23 p/Share
943 Reduced 4.2%
21,520 Common shares without ...
Mar 13 2020
SELL
Open market or private sale
$869,200 $82.0 p/Share
10,600 Reduced 32.06%
22,463 Common shares without ...
PPB

Philip P Boudreau

EVP AND CFO
Abbott Park, IL

Track Institutional and Insider Activities on ABT

Follow ABBOTT LABORATORIES and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT